ID: ALA5218704

Max Phase: Preclinical

Molecular Formula: C20H8O4Se

Molecular Weight: 391.24

Associated Items:

Representations

Canonical SMILES:  O=c1c2ccccc2c(=O)c2c1[se]c1c(=O)c3ccccc3c(=O)c12

Standard InChI:  InChI=1S/C20H8O4Se/c21-15-9-5-1-3-7-11(9)17(23)19-13(15)14-16(22)10-6-2-4-8-12(10)18(24)20(14)25-19/h1-8H

Standard InChI Key:  KWTPRHCAVLVSSX-UHFFFAOYSA-N

Associated Targets(Human)

HL-60 67320 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

B16 5829 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 391.24Molecular Weight (Monoisotopic): 391.9588AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Nagao H, Ninomiya M, Sugiyama H, Itabashi A, Uno K, Tanaka K, Koketsu M..  (2022)  Comparative analysis of p-terphenylquinone and seriniquinone derivatives as reactive oxygen species-modulating agents.,  76  [PMID:36126897] [10.1016/j.bmcl.2022.128992]

Source